Diagnosis

This video provides explanations for the correct production of sputum for the diagnosis of TB.

The mobile application was designed to make it easy to view CDC’s latest LTBI recommendations on an iPad, iPhone, iPod Touch, or Android. When your device is connected to wireless or cellular service, the content is updated automatically to ensure you always have the most up-to-date information.

This fact sheet provides information on the Xpert MTB/RIF Assay.

The International Standards for Tuberculosis Care describe a level of care that all practitioners should seek to provide in managing patients with known or suspected TB. The Standards are intended to facilitate the effective engagement of all care providers in delivering high-quality care for patients of all ages.

This set of 11 training modules on the Xpert MTB/RIF assay was developed by Global Laboratory Initiative partners, including FIND, KNCV, USAID, CDC and WHO. The modules include topics such as biosafety, specimen collection and transportation, supplies management, installation, Xpert MTB/RIF procedures, recording and reporting, and troubleshooting.

This guide was developed by the Global Laboratory Initiative, which is one of the Working Groups of the Stop TB Partnership. The guide replaces both the 1998 WHO and 2000 IUATLD guides on smear microscopy and contains many new elements.

The purpose of this training toolkit is to build the capacity of health care workers to address and manage TB in children. The toolkit consists of ten modules. Topics include epidemiology of childhood TB, diagnosis, treatment, prevention, TB/HIV co-infection, multidrug-resistant TB, and community-based child TB management.

This webinar describes the different NAATs (nucleic acid amplification tests) that are available, including the Gen-Probe MTD test, the Xpert MTB/RIF test, and Pyrosequencing (PSQ), as well as rapid molecular tests for drug resistance, including PSQ, line probe assays, and the CDC MDDR Service.

This brief online course allows users to test their knowledge regarding the Xpert MTB/RIF assay.

This pocket guide is intended to assist clinicians in managing patients with HIV and  LTBI, and drug-susceptible pulmonary TB disease. The guide includes signs and symptoms, adult dosing, dosage forms, drug-drug interactions, side effects, and patient counseling points.